NEWS

How One CEO Is Changing Life Sciences Innovation

Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on…    Read more

CEO of Paragon Biosciences On Why Innovation In Pharma Is Hard

Jeff Aronin, who is the founder, chairman and CEO of Paragon Biosciences, spoke with Chief Executive about why healthcare is stagnant from an innovation standpoint, the importance in doing meaningful work and more. Read about Jeff Aronin’s…    Read more